Resternotomy Clinical Trial
— Volu-CABGOfficial title:
Impact of Fluid Resuscitation Protocol on the Incidence of Reoperation for Bleeding After Emergency Cardiopulmonary Bypass Grafting
Verified date | June 2023 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a retrospective data analysis of patients that underwent elective or emergency cardiopulmonary bypass. Resternotomy due to bleeding is frequent after sternotomy. Also due to implementation of Argipressin into clinical practice fluid resuscitation protocol has changed to more vasopressors and less fluid within the past five years. The investigators want to explore the influence of volume resuscitation protocol on incidence of rethoracotomy during the past twenty years.
Status | Active, not recruiting |
Enrollment | 3000 |
Est. completion date | June 30, 2024 |
Est. primary completion date | May 31, 2021 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Inclusion Criteria: - All patients that underwent elective or emergency aortocoronary bypass at the University Hospital Basel between 2009 and 2020. Exclusion Criteria: - None. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Resternotomy | Resternotomy yes or no after elective or emergency aortocoronary bypass | 7 days |